Dr. Damien M. Miran, MD

Dr. Miran practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Miran's NPI, 1023403136, was assigned on April 6, 2015. Dr. Miran graduated from University of Texas Southwestern Medical School at Dallas in 2015. Dr. Miran holds Massachusetts license 278443.

Dr. Miran's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Miran's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Miran is also affiliated with Dana-Farber Cancer Institute. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Miran to 1 more hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Miran practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Miran's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Miran is licensed in Massachusetts.

CMS data shows 95 Medicare services from Dr. Miran across 2 procedure codes in 2024, for 83 Medicare patients. Medicare paid $12,068 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 83 Medicare patients who saw Dr. Miran in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have anxiety, and 75% have high blood pressure. 33% are also on Medicaid. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Miran's median patient age at 58, with 64% women.

In 2024, Dr. Miran wrote 77 Medicare Part D claims for 13 patients. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $128 in total drug cost. In 2023, CMS named 105 claims across 8 drugs.

Dr. Miran accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Miran, published from 2022 to 2024. 2022 was the busiest year, with 2. The most frequent topics are Hematopoietic Stem Cell Transplantation. Dr. Miran has published most often in Transplant Cell Ther. Dr. Miran's most frequent co-authors are Hermioni L. Amonoo, MD, Ilana Monica Braun, MD and Sheila Chitsaz Lahijani, MD.

Dr. Miran graduated from University of Texas Southwestern Medical School at Dallas in 2015.